Biogen vet jumps to CSO at Third Rock Treg biotech; Karuna CEO is stepping down, but this isn’t goodbye

Ellen Cahir-McFarland

Just a few days into her new job, Ellen Cahir-McFarland’s office is being emptied.

Cahir-McFarland, formerly head of research at Annexon, is the new chief scientific officer of Abata Therapeutics, a preclinical biotech that’s developing regulatory T cell, or Treg,…